anonymous
Guest
anonymous
Guest
Drug has been an absolute disaster and with good reason. CMS cannot ease up on the restrictions, where inevitably we will see more side effects and no true patient improvement. Biogen doesn't want a clinical study, not simply because of the cost, they know there will be no improvement over placebo. It really is that simple.
When CMS announces there will still be a required clinical trial, Biogen has already stated they will not move forward clearly showing they really don't believe in the drug.
Monday, April 11th should be the last work day for Adu.
When CMS announces there will still be a required clinical trial, Biogen has already stated they will not move forward clearly showing they really don't believe in the drug.
Monday, April 11th should be the last work day for Adu.